Goldman Sachs has flagged Insmed Inc. as a potential merger candidate under the pro-business policies of the incoming Donald ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Drug maker Insmed (INSM) is rising 6% today after it released on Friday afternoon its estimate of the revenue generated by ...

Undoubtedly, after years of neglect, bronchiectasis has become a focus of respiratory research, largely thanks to the establishment of various bronchiectasis registries. Baseline data from registries ...

Insmed (INSM) reported preliminary 2024 revenue results for its drug Arikayce and issued 2025 revenue guidance. Read more ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Dr. Andy Whittamore, a GP and clinical lead at Asthma and Lung UK, shed light on four chronic lung conditions that tend to ...

A former nurse with multiple health conditions says she "owes her life" to support groups she says helped her through the ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...